300 Medical Innovation Citizen Panelists to Take Part in Deliberative Forum on Nov. 7-8

A public deliberation process will begin to gather public opinion on whether to extend the point at which life-sustaining treatment may be withheld or withdrawn from the dying process to the terminal stage of an illness, and whether decision-making authority should be granted to people other than family members when patients have difficulty expressing their wishes.


"Who Decides When to Withdraw Life-Sustaining Treatment?"... Public Deliberation on End-of-Life Care and Support View original image

The Ministry of Health and Welfare and the Medical Innovation Committee announced on November 6 that they will hold the Second Public Deliberation Forum of the Medical Innovation Citizen Panel on Strengthening End-of-Life Medical Care and Support at Seoul National University's Siheung Campus on November 7 and 8. About 300 citizen panelists recruited with consideration for factors such as gender, age, and region will discuss three issues: when life-sustaining treatment may be withheld or withdrawn, who may make decisions on a patient's behalf, and ways to support end-of-life medical care and support.


This public deliberation will examine the institutional and social challenges involved in providing necessary medical care and support while respecting the autonomy and dignity of patients at the end of life. The Medical Innovation Citizen Panel is a representative group of members of the public formed to incorporate diverse public opinions into discussions on medical policy. In July, it took part in the first public deliberation, which focused on "Revitalizing Regional and Essential Medical Care."


On the first day, participants will discuss when life-sustaining treatment may be withheld or withdrawn. Experts will present and answer questions on two options: allowing treatment to be withheld or withdrawn only after a patient has entered the dying process, as under the current system, or extending the point at which this may happen to the terminal stage of an illness, before the patient enters the dying process. After reviewing the issues and concerns related to each option, the citizen panelists will exchange views in small-group discussions.


On the second day, participants will discuss who may make decisions on a patient's behalf regarding life-sustaining treatment, as well as ways to support end-of-life medical care and support. They will consider whether the current family-centered approach to surrogate decision-making needs to change and, if decision-making authority is granted to someone other than a family member, how to determine its scope. Key issues will also include who should make decisions when a patient's wishes cannot be confirmed and there is no one available to make decisions on the patient's behalf, as well as what procedures and safeguards are needed.


Participants will then discuss the medical care and support needed by patients who have decided not to receive life-sustaining treatment. They will gather views on where patients should spend the end of their lives and what medical care and support should be provided to make this possible.


The opening and closing ceremonies, expert presentations, and summaries of small-group discussions will be livestreamed on the Ministry of Health and Welfare's YouTube channel. Small-group discussions, however, will be held behind closed doors to allow citizen panelists to express their views freely and deliberate thoroughly.


The Citizen Panel Steering Committee plans to compile the results of the public deliberation and report them to the Medical Innovation Committee at the end of November. The results will be used in discussions on medical innovation to strengthen end-of-life medical care and support, as well as in discussions by the Special Committee on Improving the Life-Sustaining Treatment Decision System under the National Bioethics Committee.



Lee Hyeong-hun, Second Vice Minister of Health and Welfare, said, "Respecting the wishes of patients at the end of life and providing them with adequate medical care and support are important challenges that must be considered together. We will listen to diverse public opinions and examine policy measures to ensure that patients receive the necessary protection and support while their dignity and autonomy are respected."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing